Imeik Technology Development Co Ltd
SZSE:300896
Imeik Technology Development Co Ltd
SZSE:300896
Price:
214.8 CNY
-1.38%
Market Closed
Updated:
May 2, 2024
Imeik Technology Development Co Ltd
Operating Income
|
Imeik Technology Development Co Ltd
Operating Income Peer Comparison
Comparables:
6160
1801
603392
S
002252
300122
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Operating Income
¥2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
23%
|
CAGR 10-Years
22%
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
See Also
What is Imeik Technology Development Co Ltd's Operating Income?
Operating Income
1.4B
CNY
1.4B
CNY
Based on the financial report for Dec 31, 2022, Imeik Technology Development Co Ltd's Operating Income amounts to 1.4B CNY.
What is Imeik Technology Development Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
72%
72%
Over the last year, the Operating Income growth was 34%. The average annual Operating Income growth rates for Imeik Technology Development Co Ltd have been 59% over the past three years , 72% over the past five years .
You don't have any saved screeners yet
